- Home
- COFS vs TNGX Comparison
COFS vs TNGX Comparison
Compare COFS & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | COFS | TNGX |
|---|---|---|
| Founded | 1898 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.2M | 1.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | COFS | TNGX |
|---|---|---|
| Price | $30.35 | $8.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $39.00 | $12.50 |
| AVG Volume (30 Days) | 160.4K | ★ 2.3M |
| Earning Date | 01-21-2026 | 11-04-2025 |
| Dividend Yield | ★ 3.85% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.72 | N/A |
| Revenue | ★ $127,930,000.00 | $66,501,000.00 |
| Revenue This Year | $82.06 | $52.80 |
| Revenue Next Year | $8.49 | N/A |
| P/E Ratio | $17.50 | ★ N/A |
| Revenue Growth | 45.55 | ★ 53.29 |
| 52 Week Low | $24.89 | $1.03 |
| 52 Week High | $36.57 | $11.20 |
Technical Indicators
Market Signals| Indicator | COFS | TNGX |
|---|---|---|
| Relative Strength Index (RSI) | 43.97 | 44.06 |
| Support Level | $29.04 | $8.30 |
| Resistance Level | $30.94 | $8.82 |
| Average True Range (ATR) | 0.83 | 0.54 |
| MACD | -0.25 | -0.13 |
| Stochastic Oscillator | 26.21 | 17.70 |
Price Performance
Historical ComparisonAbout COFS ChoiceOne Financial Services Inc.
ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.